The development of biomarkers for Alzheimer disease (AD) has led to the origin of suspected non-AD pathophysiology (SNAP) — a heterogeneous biomarker-based concept that describes individuals with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results